scholarly journals Pressure injury in Australian public hospitals: a cost-of-illness study

2015 ◽  
Vol 39 (3) ◽  
pp. 329 ◽  
Author(s):  
Kim-Huong Nguyen ◽  
Wendy Chaboyer ◽  
Jennifer A. Whitty
Keyword(s):  
Health System ◽  
Cost Of Illness ◽  
Healthcare Spending ◽  
Public Hospitals ◽  
The Public ◽  
Australian Health ◽  
Illness Study ◽  
Pressure Injury ◽  
Bed Days ◽  
Cost Of Illness Study

Objective Pressure injuries (PI) are largely preventable and can be viewed as an adverse outcome of a healthcare admission, yet they affect millions of people and consume billions of dollars in healthcare spending. The existing literature in Australia presents a patchy picture of the economic burden of PI on society and the health system. The aim of the present study was to provide a more comprehensive and updated picture of PI by state and severity using publicly available data. Methods A cost-of-illness analysis was conducted using a prevalence approach and a 1-year time horizon based on data from the existing literature extrapolated using simulation methods to estimate the costs by PI severity and state subgroups. Results The treatment cost across all states and severity in 2012–13 was estimated to be A$983 million per annum, representing approximately 1.9% of all public hospital expenditure or 0.6% of the public recurrent health expenditure. The opportunity cost was valued at an additional A$820 million per annum. These estimates were associated with a total number of 121 645 PI cases in 2012–13 and a total number of 524 661 bed days lost. Conclusions The costs estimated in the present study highlight the economic waste for the Australian health system associated with a largely avoidable injury. Wastage can also be reduced by preventing moderate injuries (Stage I and II) from developing into severe cases (Stage III and IV), because the severe cases, accounting for 12% of cases, mounted to 30% of the total cost.

scholarly journals Cutaneous melanoma: cost of illness under Brazilian health system perspectives

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Cassia Rita Pereira da Veiga ◽  
Claudimar Pereira da Veiga ◽  
Alceu Souza ◽  
Alberto Julius Alves Wainstein ◽  
Andreia Cristina de Melo ◽  
...  
Keyword(s):  
Health System ◽  
Cost Of Illness ◽  
Value Chain ◽  
Advanced Disease ◽  
Early Stage ◽  
Decision Makers ◽  
Health Value ◽  
Illness Study ◽  
The Cost ◽  
Cost Of Illness Study

Abstract Background The landscape of cutaneous melanoma (CM) diagnosis, staging, prognosis, and treatment has undergone fundamental changes in the past decade. While the benefits of new health resources are recognized, there is a distinct lack of accurate cost-of-illness information to aid healthcare decision makers. Methods The cost-of-illness study for CM was conducted from the perspective of two health systems in Brazil: the public health system (Unified Health System, SUS) and the private health system (Health Management Organization, HMO). The study considered the direct medical cost in a bottom-up analysis, using melanoma incidence, knowledge of the disease’s progression, and the overall survival rates. The executional costs for the complete healthcare delivery cycle were investigated considering different disease stages and possible clinical course variations. The structural cost was assessed qualitatively considering the health value chain in Brazil. Results CM represents a critical financial burden in Brazil, and the cost of illness varied according to the health system and by stage at diagnosis. HMO patient costs are approximately 10-fold and 90-fold more than a SUS patient in the early-stage and advanced disease, respectively. Overall, spending on advanced disease patients can be up to 34-fold (SUS) or 270-fold (HMO) higher than that required for the early-stage disease. Given the massive amount of resources spent by the SUS and HMO, significant efforts must be made to improve the health value chain to deliver the right mix of medical care goods and services using available resources. Conclusion The cost-of-illness study for CM has the potential to inform policymakers and decision-makers regarding the economic burden that melanoma impose on a society in terms of the use of health care services, assisting them in making projections of future health care costs and resource allocation decisions. We believe that cost-of-illness analysis from a strategic perspective could be of help in assessing executional costs and be used to support the change in structural costs required for long-term strategies related to the health value chain.

scholarly journals Snakebite envenomation in the Brazilian Amazon: a cost-of-illness study

2020 ◽  
Vol 114 (9) ◽  
pp. 642-649 ◽  
Author(s):  
Samara Freire Valente Magalhães ◽  
Henry Maia Peixoto ◽  
Jacqueline de Almeida Gonçalves Sachett ◽  
Sâmella S Oliveira ◽  
Eliane Campos Alves ◽  
...  
Keyword(s):  
Health System ◽  
Cost Of Illness ◽  
Premature Death ◽  
Brazilian Amazon ◽  
System Perspective ◽  
Illness Study ◽  
Absence From Work ◽  
The Cost ◽  
Cost Of Illness Study ◽  
Health System Perspective

Abstract Background Snakebites account for significant morbidity and mortality. Their occurrence in the Brazilian Amazon warrants an analysis that will enable better understanding of their economic impact and thus contribute to their management and prevention. This study aimed to estimate the cost of snakebite envenomation in the Brazilian Amazon in 2015. Methods We conducted a cost-of-illness study of snakebite in the Brazilian Amazon in 2015 based on official surveillance data to estimate burden from a societal, patient and public health system perspective. Direct medical costs were estimated via a top-down approach. Loss of productivity was estimated by a human capital approach. Results The study included 11 503 cases and 56 deaths. The estimated cost to the health system was US$3.115.861,28. The estimated cost due to premature death caused by snakebite was US$3031 300.38. The cost attributed to the loss of productivity due to absence from work was US$1539 518.62. The estimated cost from the patient's perspective was US$268 914.18. Therefore the total cost of snakebite in the Brazilian Amazon was estimated to be almost than US$8 million in 2015. Conclusions The economic burden of snakebite in Brazilian Amazon is notably high. Snakebites cause loss of productivity through inpatient treatment or deaths.

scholarly journals Burden of Congenital Hyperinsulinism In The United Kingdom: A Cost of Illness Study

2016 ◽  
Vol 19 (7) ◽  
pp. A585
Author(s):  
S Eljamel ◽  
JS Evans ◽  
A Griffiths ◽  
I Banerjee ◽  
K Hussain ◽  
...  
Keyword(s):  
United Kingdom ◽  
Cost Of Illness ◽  
Congenital Hyperinsulinism ◽  
The United Kingdom ◽  
Illness Study ◽  
Cost Of Illness Study

Obesity and overweight in Canada: an updated cost-of-illness study

2010 ◽  
Vol 11 (1) ◽  
pp. 31-40 ◽  
Author(s):  
A. H. Anis ◽  
W. Zhang ◽  
N. Bansback ◽  
D. P. Guh ◽  
Z. Amarsi ◽  
...  
Keyword(s):  
Cost Of Illness ◽  
Obesity And Overweight ◽  
Illness Study ◽  
Cost Of Illness Study

scholarly journals Metastatic Prostate Cancer and Skeletal Related Events, a Cost of Illness Study

2014 ◽  
Vol 17 (7) ◽  
pp. A626
Author(s):  
J.W. Geenen ◽  
R. Heine ter ◽  
G.W. Frederix ◽  
A. Hövels ◽  
M. Vulpen, van ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cost Of Illness ◽  
Metastatic Prostate Cancer ◽  
Illness Study ◽  
Skeletal Related Events ◽  
Cost Of Illness Study

scholarly journals Health Insurance Cost of Raynaud Syndrome In Hungary: A Nationwide Cost of Illness Study

2018 ◽  
Vol 21 ◽  
pp. S29-S30
Author(s):  
T Gazsó ◽  
I Boncz ◽  
A Sebestyén ◽  
D Endrei
Keyword(s):  
Health Insurance ◽  
Cost Of Illness ◽  
Insurance Cost ◽  
Illness Study ◽  
Cost Of Illness Study

scholarly journals The concept of public health. Types of health systems. Parallel between the Romanian and the Australian health system

2021 ◽  
Vol 68 (1) ◽  
pp. 17-21
Author(s):  
Dorel Dulău ◽  
◽  
Simona Bungău ◽  
Lucia Daina ◽  
Camelia Buhaş ◽  
...  
Keyword(s):  
Public Health ◽  
Health System ◽  
Health Systems ◽  
Medical Management ◽  
Local Authority ◽  
Public Health System ◽  
Point Of View ◽  
The Public ◽  
Australian Health ◽  
Centralization And Decentralization

Medical management is a field that combines, both in theory and in practice, two somewhat different domains, administration and the medical domain, creating a third area of activity, namely that of medical management. This review is part of a study of health services management, which seeks to find solutions to improve the efficiency of the the management and administration of the medical system, both locally and nationally. In order to be able to study and evaluate, from a scientific point of view, the concepts of centralization and decentralization of the public health system in Romania, it is absolutely pertinent, but also mandatory, to focus on defining the notion of health system. Only later can we approach and research the process of decentralization of health, the political and economic context in which it can be initiated, as well as how to activate and carry it out. Decentralization, as a phenomenon of the transfer of rights and obligations, from the level of the central authority to the level of the local authority, can take various forms. From a theoretical and practical point of view, the forms of decentralization can be studied, evaluated and concluded by emphasizing the strengths and weaknesses. Also important to study are the ways of putting health systems into practice, which from the point of view of the source of funding are divided into state-funded health systems (Semashko, Beveridge and Bismarck) and privately funded health systems.

Sign in / Sign up

Export Citation Format

Share Document